Latest news for Fosun Tourism Gr (OTC:FSNGF) Stock

Fosun Tourism Group is predominantly engaged in providing pioneering and family-focused tourism and leisure solutions. The company is organized into business units based on its products and services and has four reportable operating segments; Club Med and others, Atlantis Sanya, Vacation asset management center segment, and Foryou Club and other services segment. Club Med and others segment that generates key revenue consists of the Club Med resort operation business and other relevant businesses such as transportation service, resort construction service, youth play, and learning service. Geographically, the company generates a majority of its revenue from its businesses in Europe, Middle East and Africa followed by Asia Pacific, and America.

Asia

Penny Stocks

Travel

Markets

General

FOSUF

FSNGF

TCOM

Key Takeaways:


	Fosun Tourism said business volume at its Atlantis Sanya mega-resort and Club Med chain rose 4.5% and 15.2%, respectively, in the first quarter


Fosun Tourism&#39;s Post-Covid Holiday Fizzles

Small Cap

LANV

Key Takeaways:


	Conglomerate Fosun International is considering a sale of some or all of its tourism unit’s two core assets to raise cash to pay down its large debt, according to Reuters
	A sale of one or both assets could drastically alter the picture for Fosun Tourism, which is 86% owned by Fosun International




Fosun Tourism At Crossroads As Parent Shops Its Two Major Assets

FOSUN TOURISM GROUP by FOSUN TOURISM GROUP

Fosun Tourism Group

AppTech Payments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APCX#NASDAQ">APCX</a>) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 46.67 percent increase over losses of $(0.15) per share from the same period last year. The company reported $43.00 thousand in sales this quarter. This is a 69.29 percent decrease over sales of $140.00 thousand the same period last year.

Earnings

Earnings Misses

News

APCX

AppTech Payments Q3 EPS $(0.08) Misses $(0.06) Estimate, Sales $43.00K Down From $140.00K YoY

Cathie Wood, CEO of asset management giant Ark Invest, suggested that Bitcoin&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) price could hit a base target of $650,000 by 2030, with an optimistic scenario reaching <a href="https://www.benzinga.com/money/bitcoin-price-prediction">as high as $1.5 million</a>. 
What Happened: Wood, a long-time Bitcoin proponent who first invested in the digital asset in 2015, attributes the surge in Bitcoin&#8217;s price to two primary factors: regulatory relief on the horizon and Bitcoin's growing distinction from other assets.
In an <a href="https://www.youtube.com/watch?v=RW2cb5KGaTg">interview</a> with CNBC on Friday, Wood said she sees institutional interest in Bitcoin intensifying, with asset allocators increasingly recognizing its unique behavior compared to traditional assets.
Ark Invest, which was the first public asset manager to gain Bitcoin exposure at $250 in 2015, maintains an optimistic outlook for the cryptocurrency's future.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41799045/ark-invests-cathie-wood-joins-call-for-strategic-bitcoin-reserve-gives-thumbs-up-to-cynthi">Ark Invest&#8217;s Cathie Wood Joins Call For Strategic Bitcoin Reserve, Gives Thumbs Up To Cynthia Lummis&#8217; Plan</a>
Wood's prediction ties into Ark Invest's broader outlook, which also includes optimism about the potential for the <a href="https://www.benzinga.com/24/11/41928272/cathie-woods-ark-invest-foresees-crypto-industry-boost-under-incoming-trump-administration">upcoming Donald Trump administration</a> to provide clearer regulations for the cryptocurrency industry in the United States.
With the end of current SEC Chair Gary Gensler&#8216;s term, the firm <a href="https://www.youtube.com/watch?v=RW2cb5KGaTg">anticipates</a> a more crypto-friendly SEC and a shift away from "regulation by enforcement," which could provide the regulatory clarity needed to spur further institutional investment.
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/global/24/11/41891628/ross-gerber-cathie-wood-or-gary-black-whose-funds-stack-up-against-sp-500s-gains-in-2024">Ross Gerber, Cathie Wood Or Gary Black? Whose Funds Stack Up Against S&amp;P 500&#8217;s Gains In 2024?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin To Hit Up To $1.5 Million By 2030, Says Cathie Wood

<a href="https://pr.report/4a65">Gladstone Commercial Corporation</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOD#NASDAQ">GOOD</a>) (the &quot;Company&quot;) announced that Terry Lee Brubaker will be retiring as Chief Operating Officer of the Company effective December 2, 2024. Mr. Brubaker is also retiring as director and executive officer of Gladstone Management Corporation, the Company&#39;s investment adviser, and as a member of the board of managers and an executive officer of Gladstone Administration, LLC, the Company&#39;s administrator, also effective December 2, 2024. Following Mr. Brubaker&#39;s departure, Michael LiCalsi, the Company&#39;s General Counsel and Secretary, who also serves as Gladstone Administration&#39;s President, General Counsel and Secretary, will assume certain additional operational responsibilities while Gladstone Management will conduct a national search for a Chief Investment Officer to fill Mr. Brubaker&#39;s investment committee responsibilities.

Management

GLAD

GOOD

Gladstone Announces Retirement Of COO Terry Lee Brubaker, Effective December 2, 2024; Michael LiCalsi, The Co's General Counsel And Secretary, Who Also Serves As Gladstone Administration's President, General Counsel And Secretary, Will Assume Certain Additional Operational Responsibilities

Insider Trades

Constellation Brands Director Richard Sands Sells 59,637 Shares At Average Price Of $240.38, Totaling $14.34M

LAND

Gladstone Land Announces Retirement Of COO Terry Lee Brubaker

<a href="https://www.globenewswire.com/Tracker?data=BVJO5xwsj0LDrAwUh3f-vBWd8O-_SqCpBG0OQjNTLTl8NV_twYqnXWKH3Tw11TbMrVsZnk_gKCIf66hPIR6PeWqOselKtKA0MlifgOq2mRRbk4p4SQOnMcFhljd8IDlL">Perspective Therapeutics, Inc.</a>&nbsp;("Perspective" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CATX#NYSE">CATX</a>), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today released details regarding the upcoming presentation of initial results from the Company-sponsored Phase 1/2a trial of [212Pb]VMT-α-NET at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium taking place November 21-23, 2024 in Chicago.
The presentation entitled "Preliminary safety and efficacy data of [212Pb]VMT-α-NET in somatostatin receptor 2 (SSTR2) expressing neuroendocrine tumors (NETs)" will be presented by Richard L. Wahl, MD, (Professor of Radiology, Mallinckrodt Institute of Radiology at Washington University School of Medicine) on Friday, November 22, 2024 at 9:05 am CT.&nbsp;&nbsp; Results of the study are also available as a poster (number C-37) at the NANETS symposium.

Biotech

CATX

Perspective Therapeutics To Discuss Data On [212Pb]VMT-α-NET Presented At The 2024 NANETS Multidisciplinary NET Medical Symposium On November 21, 2024

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4304665-1&amp;h=2441800747&amp;u=http%3A%2F%2Fwww.federalrealty.com%2F&amp;a=Federal+Realty+Investment+Trust">Federal Realty Investment Trust</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRT#NYSE">FRT</a>) announced today that Jeffrey S. Berkes, the Company's President and Chief Operating Officer, will be leaving the company effective December 31, 2024. Don Wood, Federal's Chief Executive Officer, commented, "Jeff has been my trusted partner and good friend here at Federal for the past 24 years and has been instrumental in growing the company and positioning the company as a leader in the industry. He's one of the finest professionals and human beings in our business. I'll surely miss working with him on a daily basis." Mr. Wood will reassume the additional position of President of the Company. The position of Chief Operating Officer will not be backfilled.
Wendy Seher, the Eastern Region President and Chief Operating Officer, a 22-year company veteran, and Jeff Kreshek, the Western Region President and Chief Operating Officer, a 13-year company veteran will continue in their senior operating roles at the Company and report directly to Mr. Wood.

Federal Realty Announces Jeffrey S. Berkes, The Company's President And Chief Operating Officer, Will Be Leaving The Company Effective December 31, 2024; Don Wood Will Reassume The Additional Position Of President Of The Company. The Position Of Chief Operating Officer Will Not Be Backfilled.

ADVM

Adverum Biotechnologies Schedules Webcast For November 18 To Present 52-Week LUNA Phase 2 And 4-Year OPTIC Clinical Data, Along With Key Pivotal Program Design

Flux Power Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLUX#NASDAQ">FLUX</a>), a developer of advanced lithium-ion energy storage solutions for electrification of commercial and industrial equipment, today provided an update regarding its previously discussed restatement process and subsequent SEC filings for the fiscal fourth quarter and year ended June 30, 2024, and the fiscal first quarter ended September 30, 2024.
On September 5, 2024, Flux announced that it had identified approximately $1.7 million of excess and obsolete inventory primarily related to product innovation and design of its products during a period of rapid growth over the last several years. A further detailed review of this and related items has resulted in estimated noncash inventory write-downs of approximately $4.4 million and related noncash warranty related items of approximately $0.5 million, totaling adjustments of approximately $4.9 million. This impact is not a one-time adjustment but impacting multiple quarters over multiple years. To properly reflect the obsolete inventory, the Company is currently in the process of restating previously issued financial statements for fiscal year 2023 and the interim periods of fiscal year 2024, which will be reflected in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2024. The Flux team has completed its internal review of the restatements and 10-K and is working with its auditors to file them as soon as practicable, which reflects a large body of work over an extended period of time. Upon completion, Flux will work to complete the 10-Q filing for the quarter ending September 30, 2024.

FLUX

Flux Identifies $4.9M In Noncash Adjustments For Obsolete Inventory And Warranty Items, Plans To Restate FY23 And FY24 Financials; 10-K And 10-Q Filings Pending Auditor Review

Lakeside Holding Limited Q1 Total Revenues $4,148,476, Down 1.6% YoY, EPS $(0.18) vs $(0.05) YoY

<h3>Gainers</h3>
<ul>
<li>Legacy Education (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LGCY#AMEX">LGCY</a>) shares moved upwards by 23.0% to $6.89 during Friday's pre-market session. The market value of their outstanding shares is at $78.3 million. The company's, Q1 earnings came out yesterday. </li>
<li>TCTM Kids IT Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCTM#NASDAQ">TCTM</a>) shares rose 19.37% to $0.96. The market value of their outstanding shares is at $9.4 million. </li>
<li>Despegar.com (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DESP#NYSE">DESP</a>) stock rose 10.96% to $16.49. The company's market cap stands at $1.1 billion. As per the press release, Q3 earnings came out yesterday. </li>
<li>Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) shares rose 7.62% to $0.43. The market value of their outstanding shares is at $27.7 million. As per the news, the Q3 earnings report came out 2 days ago. </li>
<li>Nerdy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRDY#NYSE">NRDY</a>) stock increased by 7.09% to $0.9. The company's market cap stands at $103.9 million. </li>
<li>WeRide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRD#NASDAQ">WRD</a>) shares increased by 6.98% to $16.89. The company's market cap stands at $4.6 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Digital Brands Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBGI#NASDAQ">DBGI</a>) stock decreased by 22.8% to $0.1 during Friday's pre-market session. The market value of their outstanding shares is at $1.0 million. The company's, Q3 earnings came out yesterday. </li>
<li>SRIVARU Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVMH#NASDAQ">SVMH</a>) shares decreased by 17.15% to $0.02. The market value of their outstanding shares is at $10.2 million. </li>
<li>Jianzhi Education Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZ#NASDAQ">JZ</a>) stock declined by 12.0% to $1.1. The company's market cap stands at $22.2 million. </li>
<li>Destination XL Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXLG#NASDAQ">DXLG</a>) stock decreased by 8.67% to $2.74. The market value of their outstanding shares is at $159.6 million. </li>
<li>Massimo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAMO#NASDAQ">MAMO</a>) shares decreased by 8.66% to $3.8. The company's market cap stands at $157.0 million. </li>
<li>Boqii Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BQ#AMEX">BQ</a>) stock declined by 8.55% to $0.44. The company's market cap stands at $2.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ALUR

DBGI

DESP

DXLG

LGCY

MAMO

NRDY

SVMH

TCTM

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>CERo Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) stock increased by 71.0% to $0.32 during Friday's pre-market session. The company's market cap stands at $48.1 million. </li>
<li>QT Imaging Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QTI#NASDAQ">QTI</a>) shares moved upwards by 18.58% to $0.58. The company's market cap stands at $12.4 million. As per the news, the Q3 earnings report came out 2 days ago. </li>
<li>TC BioPharm (Holdings) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBP#NASDAQ">TCBP</a>) shares rose 18.02% to $0.77. </li>
<li>Alpha Teknova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKNO#NASDAQ">TKNO</a>) stock rose 14.17% to $7.49. The market value of their outstanding shares is at $399.2 million. </li>
<li>Gain Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GANX#NASDAQ">GANX</a>) shares rose 14.04% to $1.99. The market value of their outstanding shares is at $50.8 million. As per the news, the Q3 earnings report came out yesterday. </li>
<li>iSpecimen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPC#NASDAQ">ISPC</a>) stock increased by 14.02% to $4.96. The market value of their outstanding shares is at $4.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TFF Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TFFP#NASDAQ">TFFP</a>) shares fell 71.9% to $0.45 during Friday's pre-market session. The market value of their outstanding shares is at $1.5 million. </li>
<li>Eyenovia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) shares decreased by 60.02% to $0.14. The market value of their outstanding shares is at $11.6 million. As per the news, the Q3 earnings report came out 3 days ago. </li>
<li>Akoya Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKYA#NASDAQ">AKYA</a>) stock declined by 31.31% to $2.15. The market value of their outstanding shares is at $106.4 million. As per the news, the Q3 earnings report came out yesterday. </li>
<li>GRI Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRI#NASDAQ">GRI</a>) shares declined by 20.85% to $0.76. The market value of their outstanding shares is at $2.8 million. As per the news, the Q3 earnings report came out yesterday. </li>
<li>Tivic Health Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) shares declined by 17.66% to $0.3. The company's market cap stands at $1.8 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Carmell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) shares decreased by 13.44% to $0.24. The company's market cap stands at $5.1 million. As per the news, the Q3 earnings report came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKYA

CERO

CTCX

EYEN

GANX

ALPS ETF Trusthen & Steers Global Realty Majors ETF

ISPC

TCBP

TFFP

TIVC

TKNO

12 Health Care Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Simpple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPPL#NASDAQ">SPPL</a>) stock moved upwards by 42.7% to $1.26 during Friday's pre-market session. The company's market cap stands at $20.4 million. </li>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) stock increased by 25.62% to $0.44. The market value of their outstanding shares is at $40.7 million. </li>
<li>1847 Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#AMEX">EFSH</a>) shares rose 19.22% to $0.57. </li>
<li>FuelCell Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCEL#NASDAQ">FCEL</a>) shares moved upwards by 18.4% to $8.3. The market value of their outstanding shares is at $169.1 million. </li>
<li>Aqua Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQMS#NASDAQ">AQMS</a>) shares rose 12.04% to $2.14. The market value of their outstanding shares is at $14.6 million. The company's, Q3 earnings came out yesterday. </li>
<li>HUHUTECH International Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUHU#NASDAQ">HUHU</a>) shares rose 6.66% to $4.8. The market value of their outstanding shares is at $101.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>iPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) stock declined by 25.0% to $0.9 during Friday's pre-market session. The company's market cap stands at $28.2 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>Expion360 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPON#NASDAQ">XPON</a>) shares decreased by 19.72% to $2.77. The company's market cap stands at $1.5 million. As per the news, the Q3 earnings report came out yesterday. </li>
<li>Microvast Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVST#NASDAQ">MVST</a>) stock fell 14.81% to $0.66. The company's market cap stands at $210.0 million. As per the news, the Q3 earnings report came out 3 days ago. </li>
<li>Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) stock fell 14.7% to $0.43. The company's market cap stands at $8.4 million. </li>
<li>AgEagle Aerial Sys (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UAVS#AMEX">UAVS</a>) shares fell 13.41% to $3.1. The market value of their outstanding shares is at $2.6 million. </li>
<li>Primech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMEC#NASDAQ">PMEC</a>) shares declined by 12.63% to $0.69. The company's market cap stands at $26.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AQMS

EFSH

FCEL

HTOO

HUHU

MVST

PMEC

SPPL

UAVS

XPON

12 Industrials Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Greenidge Generation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GREE#NASDAQ">GREE</a>) shares rose 55.8% to $3.85 during Friday's pre-market session. The market value of their outstanding shares is at $42.9 million. </li>
<li>Greenidge Generation Holdings Inc. - 8.50% Senior Notes due 2026 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GREEL#NASDAQ">GREEL</a>) stock increased by 15.78% to $11.0. </li>
<li>Red Cat Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) shares moved upwards by 15.42% to $4.64. The market value of their outstanding shares is at $349.8 million. </li>
<li>Brand Engagement Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) shares moved upwards by 15.08% to $0.83. The company's market cap stands at $31.5 million. As per the news, the Q3 earnings report came out yesterday. </li>
<li>Zeta Global Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) shares increased by 14.85% to $19.95. The company's market cap stands at $4.7 billion. The company's, Q3 earnings came out 4 days ago. </li>
<li>Abits Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABTS#NASDAQ">ABTS</a>) shares moved upwards by 12.76% to $0.6. The market value of their outstanding shares is at $21.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Quantum Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) shares declined by 33.4% to $2.93 during Friday's pre-market session. The market value of their outstanding shares is at $290.3 million. </li>
<li>Wellchange Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WCT#NASDAQ">WCT</a>) shares fell 13.97% to $3.57. The market value of their outstanding shares is at $75.9 million. </li>
<li>FOXO Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#AMEX">FOXO</a>) stock decreased by 12.99% to $0.58. The company's market cap stands at $7.9 million. </li>
<li>Mercurity Fintech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFH#NASDAQ">MFH</a>) shares decreased by 10.09% to $3.21. The company's market cap stands at $195.2 million. </li>
<li>Applied Mat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) stock fell 9.5% to $168.34. The market value of their outstanding shares is at $139.3 billion. As per the press release, Q4 earnings came out yesterday. </li>
<li>Nano Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) shares fell 8.1% to $4.2. The company's market cap stands at $41.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABTS

AMAT

BNAI

FOXO

GREE

Greenidge Generation Holdings Inc. - 8.50% Senior Notes due 2026

GREEL

QUBT

RCAT

ZETA

12 Information Technology Stocks Moving In Friday's Pre-Market Session

Offerings

BTCT

BTC Digital Issued 727,425 Shares Via Cashless Exercises In Response To Notices On November 13; Announced An Additional 120,372 Shares Issued On November 15 After Further Exercise Notices

Ratings for Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) were provided by 30 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">7</td>
<td align="right">14</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">6</td>
<td align="right">11</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $178.53, with a high estimate of $205.00 and a low estimate of $140.00. Witnessing a positive shift, the current average has risen by 10.03% from the previous average price target of $162.25.
<img src="https://www.benzinga.com/files/images/story/2024/1731704548_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of Oracle among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jason Ader</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$200.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Alex Zukin</td>
<td>RBC Capital</td>
<td>Announces</td>
<td>Sector Perform</td>
<td>$165.00</td>
<td>-</td>
</tr>
<tr>
<td>Patrick Walravens</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$205.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Mark Moerdler</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Outperform</td>
<td>$202.00</td>
<td>$201.00</td>
</tr>
<tr>
<td>Brent Thill</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$190.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$140.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Karl Keirstead</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$200.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Jason Ader</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$190.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Brad Sills</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$195.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$202.00</td>
<td>$172.00</td>
</tr>
<tr>
<td>Derrick Wood</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$190.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Patrick Walravens</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$175.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Kirk Materne</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$190.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>John Difucci</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Buy</td>
<td>$200.00</td>
<td>$185.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$185.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Tyler Radke</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$157.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Patrick Walravens</td>
<td>JMP Securities</td>
<td>Announces</td>
<td>Market Outperform</td>
<td>$175.00</td>
<td>-</td>
</tr>
<tr>
<td>Brent Thill</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$170.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Keith Bachman</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$173.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Brad Reback</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$155.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Jason Ader</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$175.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$172.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$140.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Siti Panigrahi</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$185.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Karl Keirstead</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$175.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Kirk Materne</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$175.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Derrick Wood</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$180.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Keith Weiss</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$145.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Brad Sills</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$175.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$175.00</td>
<td>$150.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Oracle. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Oracle compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Oracle's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Oracle's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ORCL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Oracle analyst ratings.</a>
<h2>Delving into Oracle's Background</h2>
Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.
<h3>Oracle's Financial Performance</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Oracle's remarkable performance in 3 months is evident. As of 31 August, 2024, the company achieved an impressive revenue growth rate of 6.86%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Oracle's net margin excels beyond industry benchmarks, reaching 22.01%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Oracle's ROE excels beyond industry benchmarks, reaching 30.01%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Oracle's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.05%, the company showcases efficient use of assets and strong financial health.
Debt Management: Oracle's debt-to-equity ratio is notably higher than the industry average. With a ratio of 7.81, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

ORCL

Expert Outlook: Oracle Through The Eyes Of 30 Analysts

4 analysts have shared their evaluations of Tetra Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEK#NASDAQ">TTEK</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $51.0, a high estimate of $56.00, and a low estimate of $47.00. This current average reflects an increase of 0.49% from the previous average price target of $50.75. 
<img src="https://www.benzinga.com/files/images/story/2024/1731704532_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The analysis of recent analyst actions sheds light on the perception of Tetra Tech by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sangita Jain</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$49.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Sabahat Khan</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$52.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Andrew Wittmann</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$47.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Sangita Jain</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$56.00</td>
<td>$49.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Tetra Tech. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Tetra Tech compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Tetra Tech's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Tetra Tech's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TTEK/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Tetra Tech analyst ratings.</a>
<h2>Get to Know Tetra Tech Better</h2>
Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. Tetra Tech has two reportable segments. Its Government Services Group (GSG) reportable segment primarily includes activities with U.S. government clients (federal, state and local) and activities with development agencies worldwide. Commercial/International Services Group (CIG) reportable segment primarily includes activities with U.S. commercial clients and international clients other than development agencies.
<h3>Tetra Tech: Financial Performance Dissected</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Tetra Tech's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 11.2%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.
Net Margin: Tetra Tech's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 6.38% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Tetra Tech's ROE stands out, surpassing industry averages. With an impressive ROE of 5.28%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Tetra Tech's ROA stands out, surpassing industry averages. With an impressive ROA of 2.1%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.63, Tetra Tech adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Analyst Ratings: Simplified</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TTEK

The Analyst Landscape: 4 Takes On Tetra Tech

NetEase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTES#NASDAQ">NTES</a>) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for NetEase, presenting an average target of $105.0, a high estimate of $120.00, and a low estimate of $82.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 12.5%. 
<img src="https://www.benzinga.com/files/images/story/2024/1731704501_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A comprehensive examination of how financial experts perceive NetEase is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alicia Yap</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$115.00</td>
<td>$108.00</td>
</tr>
<tr>
<td>Fawne Jiang</td>
<td>Benchmark</td>
<td>Lowers</td>
<td>Buy</td>
<td>$105.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Jiong Shao</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$82.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Eddie Leung</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$120.00</td>
<td>$142.00</td>
</tr>
<tr>
<td>Thomas Chong</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$103.00</td>
<td>$126.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to NetEase. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of NetEase compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into NetEase's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/NTES/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on NetEase analyst ratings.</a>
<h2>Discovering NetEase: A Closer Look</h2>
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
<h3>Unraveling the Financial Story of NetEase</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: NetEase's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 6.14%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Communication Services sector.
Net Margin: NetEase's net margin is impressive, surpassing industry averages. With a net margin of 26.52%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 5.24%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): NetEase's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 3.57%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.1, NetEase adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NTES

NetEase Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

Rockwell Automation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) underwent analysis by 10 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $296.1, with a high estimate of $335.00 and a low estimate of $255.00. Surpassing the previous average price target of $276.38, the current average has increased by 7.14%.
<img src="https://www.benzinga.com/files/images/story/2024/1731704489_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The perception of Rockwell Automation by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Chris Snyder</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$335.00</td>
<td>$320.00</td>
</tr>
<tr>
<td>Chris Snyder</td>
<td>UBS</td>
<td>Announces</td>
<td>Neutral</td>
<td>$313.00</td>
<td>-</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$255.00</td>
<td>$245.00</td>
</tr>
<tr>
<td>Noah Kaye</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$300.00</td>
<td>$288.00</td>
</tr>
<tr>
<td>Richard Eastman</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$290.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Andrew Obin</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$285.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Brett Linzey</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$270.00</td>
<td>$245.00</td>
</tr>
<tr>
<td>Noah Kaye</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$288.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Joseph O'Dea</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$305.00</td>
<td>$293.00</td>
</tr>
<tr>
<td>Chris Snyder</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Overweight</td>
<td>$320.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Rockwell Automation. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Rockwell Automation compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Rockwell Automation's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Rockwell Automation's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/ROK/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Rockwell Automation analyst ratings.</a>
<h2>All You Need to Know About Rockwell Automation</h2>
With roots tracing back to the early 1900s, Rockwell Automation is the successor to Rockwell International, which spun off its avionics segment in 2001. It is a pure-play industrial automation company that operates through three segments. Its largest segment by revenue, intelligent devices, sells factory floor-level devices such as motors, drives, sensors, relays, and actuators. Its software &amp; control segment sells visualization, simulation, and human-machine interface software and control products such as programmable controllers, computers, and operator terminals. Its smallest segment, lifecycle services, offers digital consulting, engineered-to-order services, and other outsourced services such as remote monitoring, cybersecurity, and asset and plant maintenance and optimization.
<h3>Rockwell Automation's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Decline in Revenue: Over the 3 months period, Rockwell Automation faced challenges, resulting in a decline of approximately -0.74% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: Rockwell Automation's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 11.75% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 7.01%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Rockwell Automation's ROA stands out, surpassing industry averages. With an impressive ROA of 2.13%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.14, caution is advised due to increased financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Rockwell Automation: Insights From 10 Analyst Reviews

<ul>
<li>Data will be presented on Monday, November 18th as a late breaker poster at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting&#xAE; 2024 in San Diego.</li>
<li>LEGEND achieved its primary efficacy endpoint by significantly lowering HbA1c level in both the lanifibranor arm and in the lanifibranor with empagliflozin arm compared to placebo.</li>
<li>50% percent of patients saw their HbA1c levels below 6.5% at week 24 following treatment with lanifibranor alone or in combination with empagliflozin.&nbsp;</li>
<li>58% of patients on lanifibranor alone and 80% of those on the combination therapy had a decrease of at least 1% in HbA1c at week 24, compared to 0% in the placebo group.</li>
<li>Liver function tests, markers of liver fibrosis and markers or cardiometabolic health including HOMA-IR, hsCRP, ferritin, lipid profile and adiponectin levels were also improved with lanifibranor alone or in combination with empagliflozin.</li>
<li>The weight gain observed in a proportion of patients under lanifibranor was not observed in patients treated with the combination of lanifibranor with empagliflozin.</li>
</ul>
Daix (France), Long Island City (New York, United States), November 15, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis ("MASH"), also known as non-alcoholic steatohepatitis ("NASH"), and other diseases with significant unmet medical needs, today announced the presentation of the final analysis of LEGEND, Phase 2 proof-of-concept clinical trial, evaluating lanifibranor in combination with empagliflozin in patients with MASH and Type 2 Diabetes (T2D). The data will be presented Monday November 18, 2024, as a late breaker poster at the American Association for the Study of Liver Diseases (AASLD)&nbsp;The Liver Meeting&#xAE;, taking place in San Diego California. &nbsp;

Inventiva To Present Data From The Final Analysis Of The Phase 2 Study Evaluating The Combination Of Lanifibranor With Empagliflozin In Patients With Mash And T2D At The AASLD The Liver Meeting Late-Breaker Session; 50% Percent Of Patients Saw Their HbA1c Levels Below 6.5% At Week 24 Following Treatment With Lanifibranor Alone Or In Combination With Empagliflozin

Fosun Tourism Gr

<h4>Key Takeaways:</h4>

<ul>
	<li>Fosun Tourism said business volume at its Atlantis Sanya mega-resort and Club Med chain rose 4.5% and 15.2%, respectively, in the first quarter</li>
	<li>The company&rsquo;s shares are trading near an all-time low, following reports earlier this year that its two major assets may be up for sale to raise cash for its debt-strapped parent</li>
</ul>

By Doug Young

There&rsquo;s not much fun these days at&nbsp;Fosun Tourism Group&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/FSNGF#OTC">FSNGF</a>), one of China&rsquo;s leading tourism companies and owner of the Club Med resort chain.

The company&rsquo;s latest&nbsp;<a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2024/0422/2024042201483.pdf">quarterly update</a>&nbsp;shows it&rsquo;s suffering from a post-Covid hangover, with its China business significantly underperforming the market. Its global business, anchored by the Club Med chain, did slightly better, but was nothing to write home about either. Meantime, the company&rsquo;s stock is down more than 40% this year and now trades at all-time lows, in sharp contrast to Chinese peers that have mostly posted strong gains this year.

So, why all the gloom at a company whose formation dates back to the roughly $1 billion purchase of Club Med in 2015 by&nbsp;Fosun International&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/FOSUF#OTC">FOSUF</a>), one of China&rsquo;s leading conglomerates? While the latest quarterly operating data isn&rsquo;t too exciting, it hardly explains Fosun Tourism&rsquo;s recent fall from grace in the investment community.

The biggest factor behind the gloom probably owes to reports in March that Fosun International was considering selling part of Club Med, as well as Fosun Tourism&rsquo;s other major asset, its Atlantis Sanya mega-resort, to raise cash to pay down its massive debt. Thus, anyone who holds Fosun Tourism stock now doesn&rsquo;t really know if the company will still own one or both of its major assets at this time next year.

At the same time, the people at Fosun Tourism are probably having difficulty staying focused on their business while knowing major changes could soon be coming.

All that said, we&rsquo;ll return to Fosun Tourism&rsquo;s first-quarter update that provides one of the first real indicators of how China&rsquo;s tourism industry will fare in the post-Covid era. This year&rsquo;s first quarter is significant in China, since it marks the first time that the latest data and year-ago comparisons are both in the country&rsquo;s post-Covid period.

That means that Covid-era volatility should be largely gone from most Chinese tourism-related companies going forward, giving a clearer picture of how the sector is doing as the Chinese economy slows and consumers become more cautious.

Previously released national data showed the sector was holding up quite well during the long Lunar New Year holiday in February despite the economic slowdown. The number of domestic trips during the weeklong period rose 34.3% to 474 million, while domestic tourism spending was up by an even stronger 47.3% to 632.7 billion yuan ($87 billion), according to government data.

But Fosun Tourism&rsquo;s data wasn&rsquo;t nearly so buoyant. Business volume at the company&rsquo;s Atlantis Sanya mega-resort was up just 4.5% to 576 million yuan during the first quarter, according to the company&rsquo;s quarterly update. The number of visits to the resort rose at a slightly faster rate of 7.5% to 2.1 million. But in a slightly ominous sign, the average daily room rate was actually down 2.8% to 2,500 yuan.

Here we should point out that year-ago figures for the resort might have been artificially high, since China ended its Covid restrictions at the end of 2022 and &ldquo;revenge travel&rdquo; was at a peak in January and February 2023 as many people took some of their first major vacations in three years during those months.

<h3>Dead&nbsp;Cat Bounce</h3>

Fosun tourism shares got a lift from the update, rising more than 5% in early trade on Tuesday. But the jump was a bit of a &ldquo;dead cat bounce,&rdquo; since the stock was previously at an all-time low, and it&rsquo;s quite likely the shares could resume their downward trend later this week.

Even after the slight rally, the stock is still well behind its peers in terms of valuation. It trades at a forward price-to-earnings (P/E) ratio of just 10, compared to a 20 for&nbsp;Trip.com&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>), China&rsquo;s leading online travel agent that has a similar mix of domestic and international business. While Fosun Tourism&rsquo;s shares are down sharply this year, Trip.com&rsquo;s stock has risen about 40% over that period.

While Sanya Atlantis posted single-digit gains, the performance was slightly better at Club Med, whose worldwide chain of resorts accounts for more than 80% of Fosun Tourism&rsquo;s business. The chain&rsquo;s business volume rose 15.2% to 6.08 billion yuan in the first quarter, while average occupancy at its rooms rose 1.4 percentage points to 76.9%. Its average bed rate rose 8.8% to 2,190 yuan.

Here, we should point out that Fosun Tourism is doing quite a bit better now, at least in terms of business volume, than it was before the pandemic. The company&rsquo;s latest overall first-quarter business volume of 7.16 billion yuan was up nearly 50% from the 4.8 billion yuan it reported in the first quarter of 2019. The big jump most likely reflects the fact that Fosun Tourism, like many of its peers, continued to upgrade existing properties and build new ones during the pandemic, in anticipation of business eventually returning to normal.

While the first-quarter numbers don&rsquo;t look too impressive, Fosun Tourism also didn&rsquo;t impress investors too much with its results for all of 2023 released last month. Those results show its revenue rose 25% last year to 17.2 billion yuan. Within the total, Sanya Atlantis posted much stronger revenue growth, with the figure nearly doubling to 1.76 billion yuan from 897 million yuan a year earlier. Club Med revenue rose by a slower 22% to 14.6 billion yuan, reflecting the fact that its business is mostly outside China and thus already began to rebound in 2022.

Still, the company&rsquo;s overall revenue growth last year was well behind the 122% growth for Trip.com, whose revenue reached 44.5 billion yuan for the period.

The bottom line is that investors have recently become quite bearish on Fosun Tourism, partly due to its underwhelming post-Covid rebound. But the bigger reason is probably the cloud hanging over the company due to its parent&rsquo;s financial difficulties, meaning no one is really sure what Fosun Tourism might look like a year from now &ndash; assuming it continues exists in its current form.

This article is from an unpaid external contributor. It does not represent Benzinga&#39;s reporting and has not been edited for content or accuracy.

Fosun Tourism's Post-Covid Holiday Fizzles

<h4>Key Takeaways:</h4>

<ul>
	<li>Conglomerate Fosun International is considering a sale of some or all of its tourism unit&rsquo;s two core assets to raise cash to pay down its large debt, according to Reuters</li>
	<li>A sale of one or both assets could drastically alter the picture for Fosun Tourism, which is 86% owned by Fosun International</li>
</ul>

By Doug Young

There&rsquo;s strategic investing, and then there&rsquo;s debt. When it comes to the two, debt seems to take precedence these days for conglomerate&nbsp;Fosun International&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/FOSUF#OTC">FOSUF</a>), which is reportedly looking to offload some or all of the two main assets in its&nbsp;Fosun Tourism Group&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/FSNGF#OTC">FSNGF</a>) unit.

Specifically, Fosun Tourism is exploring a potential sale of some or all of its Atlantis Sanya mega-resort on South China&rsquo;s Hainan island, according to a&nbsp;<a href="https://www.reuters.com/markets/deals/chinas-fosun-explores-sale-atlantis-sanya-luxury-resort-sources-say-2024-03-05/">Reuters report</a>&nbsp;this week. It&rsquo;s also exploring a similar sale of a stake in its core Club Med resort chain, Reuters reported last month. All of this comes after Fosun International, which owns 78% of Fosun Tourism, has said repeatedly in the past that it considers tourism one of its core areas and has no intent to sell that business.

Perhaps that was true in the past, though if it really sells the Atlantis resort and part of Club Med, there won&rsquo;t be much left to the company&rsquo;s tourism operation. Reuters also previously reported in January that Fosun was in advanced talks to sell one of its other tourism-related assets, the Thomas Cook package holiday tour company, to Poland&rsquo;s eSky.

After the latest report, Fosun Tourism issued a statement saying it &ldquo;consistently evaluates and optimizes its business portfolio.&rdquo; Its lack of a denial this time, which differs from Fosun&rsquo;s response in the past to similar reports, seems to indicate that the company is indeed shopping Atlantis and also a stake in Club Med.

The bigger story is that Fosun, which is anchored by its Fosun International flagship, is one of the last major Chinese conglomerates still standing after messy collapses of rivals like HNA and Anbang that went on massive debt-fueled global buying sprees in the 2010s. Fosun was one of the better-run conglomerates in the group, which is partly why it has yet to suffer a similar fate. The company has strong ties with the Shanghai government, which helps as well.

That Shanghai government connection is reflected in the fact that Fosun is targeting big state-owned enterprises (SOEs) to buy the Atlantis resort, as well as deep-pocketed Middle Eastern investors, according to Reuters. SOEs are famous for stepping in with financial and other lifelines when a local government wants to rescue one of its struggling local champions. We saw a similar rescue from the city of Shenzhen last year when local real estate giant Vanke ran into similar difficulties due to its similarly heavy debt load.

Fosun&rsquo;s heavy debts are no secret, and totaled about $30 billion as of last June. The company has previously said it would sell down non-strategic assets to pay down some of that, though, again, it previously emphasized that tourism and pharmaceuticals are two areas it considers strategic.

Thus, this latest report seems to indicate that Fosun no longer considers tourism to be quite as strategic as it previously did. What Fosun Tourism might look like after the sales of some or all of its two largest assets is anyone&rsquo;s guess.

<h3>Fate Of Fosun Tourism&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>

It&rsquo;s quite possible Fosun Tourism could continue as a listed company, even without the Atlantis resort that accounted for about 10% of its revenue in its latest financial report for the first half of last year. It&rsquo;s also possible Fosun International could ultimately disband the tourism unit and focus on its other core areas, which include its&nbsp;Fosun Pharmaceuticals&nbsp;(2196.HK; 600196.SH) and&nbsp;Lanvin&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LANV#NYSE">LANV</a>) luxury goods business.

At the very least, the latest talks seem to indicate that tourism is no longer the sacred cow that it once was in terms of assets that weren&rsquo;t for sale.

Shares of both Fosun International and Fosun Tourism sagged after publication of the Reuters report on Tuesday, with each ticker down about 6% over the next three trading days. Both stocks have been under a bit of pressure lately, with Fosun Tourism now trading at a forward price-to-earnings (P/E) ratio of just 8. That&rsquo;s half the 16 for online travel agent&nbsp;Trip.com&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>), and less than a third of the 29 forward P/E for&nbsp;Hilton Worldwide&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>), which is also a major resort operator.

The low valuation for Fosun Tourism seems to reflect worries about its parent&rsquo;s debt, rather than any problems at the actual company. In fact, Fosun Tourism is doing quite well these days thanks to a post-pandemic travel rebound that is benefiting tourism companies worldwide.

The company issued a&nbsp;<a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2024/0201/2024020100749.pdf">profit alert</a>&nbsp;last month saying business volume from its tourism operation grew 15% or more in 2023, and the figure was up 25% or more from pre-pandemic levels in 2019. Interestingly, calculations using data in the profit alert showed the company will record a loss of about 200 million yuan ($27.8 million) in the second half of last year, reversing a 472 million yuan profit in the first half. But the loss is probably due to factors such as one-time charges, since business in general was quite good for the tourism sector.

&ldquo;The company&rsquo;s business operations are performing well now, and its financial condition is stable,&rdquo; Fosun Tourism said in the statement in response to the Reuters report on a potential Atlantis sale.

Atlantis is a massive resort with more than 1,300 guest rooms, as well as facilities including a water park and shopping mall. Construction began on the property in 2014 and was completed four years later, and Fosun reportedly said it had invested 11 billion yuan in the property &ndash; or roughly $1.5 billion &ndash; as of 2018.

Atlantis Sanya&rsquo;s revenue jumped 89% year-on-year in the first half of last year to 928 million yuan, and its revenue per available room (revpar), a common industry metric, rose by a similar 82% to 2,075 yuan. Club Med accounted for the lion&rsquo;s share of Fosun Tourism&rsquo;s revenue in the first half of last year, about 84%, and was also up 34% during the period to 7.5 billion yuan.

At the end of the day, Fosun is probably exploring all of its options to pay down its debt, even for its tourism assets that it previously said weren&rsquo;t on the table. Given the current positive environment for tourism, the company might even be able to pocket some tidy profits on its Club Med and Atlantis investments if it can find the right buyer.

This article is from an unpaid external contributor. It does not represent Benzinga&#39;s reporting and has not been edited for content or accuracy.

Comments

Fosun Tourism Gr

News

Latest news for Fosun Tourism Gr (OTC:FSNGF) Stock

Tuesday, April 23, 2024

Friday, March 08, 2024

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga